Skip to main content

MJFF Publications

1681 - 1690 of 7730 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • RESTRICTED
    Title: Vocal changes in a zebra finch model of Parkinson’s disease characterized by alpha-synuclein overexpression in the song-dedicated anterior forebrain pathway
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0265604
    Citation Count: 6
  • RESTRICTED
    Title: Comparative analysis of machine learning algorithms for multi-syndrome classification of neurodegenerative syndromes
    Journal Name: Alzheimer's Research & Therapy
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13195-022-00983-z
    Citation Count: 11
  • RESTRICTED
    Title: Hallucinations and delusions associated with Parkinson’s disease psychosis: safety of current treatments and future directions
    Journal Name: Expert Opinion on Drug Safety
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1080/14740338.2022.2069240
    Citation Count: 8
  • RESTRICTED
    Title: Incidence of Parkinson Disease in North America (P1-1.Virtual)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.98.18_supplement.2665
    Best OA location URL:
    Citation Count: 1
  • RESTRICTED
    Title: Parkinson’s Progression Markers Initiative (PPMI) Online expands biomarker research in Parkinson’s disease (PD) (P9-11.006)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.98.18_supplement.1529
    Best OA location URL:
    Citation Count: 1
  • RESTRICTED
    Title: SHIP164 is a chorein motif lipid transfer protein that controls endosome–Golgi membrane traffic
    Journal Name: Journal of Cell Biology
    Publisher: Rockefeller University Press
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1083/jcb.202111018
    Citation Count: 13
  • RESTRICTED
    Title: Sleep, Pain, and Neurodegeneration: A Mendelian Randomization Study
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2022.765321
    Citation Count: 9
  • RESTRICTED
    Title: Structural basis for feedforward control in the PINK1/Parkin pathway
    Journal Name: The EMBO Journal
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.15252/embj.2021109460
    Citation Count: 17
  • RESTRICTED
    Title: Abstracts
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.13411
    Citation Count: 5
  • RESTRICTED
    Title: Alternative protective group strategy for the radiosynthesis of Flortaucipir 18F
    Journal Name: Nuclear Medicine and Biology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s0969-8051(22)00208-6
    Best OA location URL:
    Citation Count: 0
Filters
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.